LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 83 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2019. The put-call ratio across all filers is 0.87 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $224,000 | -31.7% | 34,800 | 0.0% | 0.00% | – |
| Q4 2018 | $328,000 | -50.8% | 34,800 | +5.1% | 0.00% | -100.0% |
| Q3 2018 | $666,000 | -31.1% | 33,100 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $966,000 | -2.0% | 33,100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $986,000 | +4.2% | 33,100 | +12.6% | 0.00% | 0.0% |
| Q4 2017 | $946,000 | -7.5% | 29,400 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,023,000 | +16.9% | 29,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $875,000 | -0.3% | 29,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $878,000 | +105.1% | 29,400 | +20.5% | 0.00% | 0.0% |
| Q4 2016 | $428,000 | -26.2% | 24,400 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $580,000 | +48.7% | 24,400 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $390,000 | -20.9% | 24,400 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $493,000 | -8.7% | 24,400 | +22.0% | 0.00% | 0.0% |
| Q4 2015 | $540,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,872,130 | $77,548,000 | 30.77% |
| RTW INVESTMENTS, LP | 1,084,416 | $29,279,000 | 9.67% |
| Avoro Capital Advisors LLC | 784,199 | $21,173,000 | 7.29% |
| Broadfin Capital, LLC | 1,165,373 | $31,465,000 | 1.94% |
| P.A.W. CAPITAL CORP | 50,400 | $1,361,000 | 1.54% |
| Belmont Global Advisors, Inc. | 37,522 | $1,013,000 | 1.31% |
| Perceptive Advisors | 649,515 | $17,537,000 | 1.30% |
| ACUTA CAPITAL PARTNERS, LLC | 82,920 | $2,239,000 | 1.07% |
| Iguana Healthcare Management, LLC | 110,000 | $2,970,000 | 0.98% |
| Virtus ETF Advisers LLC | 10,250 | $277,000 | 0.76% |